event 1,074 words
Contents

mTOR Signaling Dysregulation in Progressive Supranuclear Palsy

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (50)

APOE-Dependent Autophagy Restoration
Score: 0.88
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.87
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.82
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.78
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.76
Circadian Clock-Autophagy Synchronization
Score: 0.76
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
Transcriptional Autophagy-Lysosome Coupling
Score: 0.76
Circadian-Synchronized Proteostasis Enhancement
Score: 0.74
APOE-TREM2 Interaction Modulation
Score: 0.74
Phase-Separated Organelle Targeting
Score: 0.73
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.73
Circadian Rhythm Entrainment of Reactive Astrocytes
Score: 0.72
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.72
Purinergic Signaling Polarization Control
Score: 0.71
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71
Autophagosome Maturation Checkpoint Control
Score: 0.71
Membrane Cholesterol Gradient Modulators
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
pg 1/3Next →

Related Analyses (29)

Does TFEB dysfunction cause neurodegeneration or represent a
neurodegeneration · completed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Related Experiments (22)

s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40

See Also (5)

AMPK (AMP-Activated Protein Kinase)
entity · KG edge: activates
ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: activates
ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: therapeutic_target
ABCG1 Gene
gene · KG edge: inhibits
ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member
gene · KG edge: therapeutic_target

Knowledge Graph (8 edges)

mTORC1-TFEB/TFE3 axis, CLEAR gene network implicates_in neurodegeneration
SQSTM1 (p62), mTORC1, TRAF6 implicates_in neurodegeneration
STIP1 activates mTOR
h-2e03f316 targets TREM2-mTOR pathway
h-b701c493b0 targets AMPK/mTOR
AMPK/mTOR targeted_by h-b701c493b0
Autophagy interacts_with mTOR
Rapamycin activates mTOR

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.